Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies

Experimental Hematology
|October 1, 1985
PubMed

Insights

Three types of human leukocyte interferons (IFN) show anti-leukemic properties by suppressing myeloblast colony formation in acute myeloid leukemia patients. Interferon-alpha-C demonstrated a more pronounced effect on primary growth, while Interferon-alpha-A maintained antiproliferative effects on secondary growth.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Acute myeloid leukemia (AML) is a hematologic malignancy characterized by uncontrolled proliferation of myeloid blasts.
  • Interferons (IFNs) are cytokines with known immunomodulatory and antiproliferative effects.
  • Recombinant DNA technology has enabled the production of specific interferon subtypes for therapeutic research.

Purpose of the Study:

  • To investigate the in vitro effects of three recombinant human leukocyte interferon subtypes (IFN alpha 2, IFN alpha-A, IFN alpha-C) on acute myeloid leukemia (AML) myeloblast colony formation.
  • To assess the dose-dependent response and self-renewal capacity of AML cells exposed to these interferons.
  • To compare the differential anti-leukemic properties of IFN alpha-A and IFN alpha-C.

Main Methods:

  • Leukemic bone marrow cells from nine AML patients were cultured in the presence of varying concentrations (10^2-10^5 U/ml) of IFN alpha 2, IFN alpha-A, and IFN alpha-C.
  • Myeloblast colony formation was assessed.
  • Self-renewal assays were performed on primary cultures to evaluate secondary colony growth.
  • Expression of the IFN-induced enzyme 2-5A synthetase was measured to confirm cellular response.

Main Results:

  • All three tested interferon subtypes exhibited a dose-dependent suppression of myeloblast colony formation in vitro.
  • A significant increase in 2-5A synthetase indicated that AML cells possess functional interferon receptors and metabolic responsiveness.
  • Interferon-alpha-C showed a more potent suppression of primary myeloblast growth compared to IFN alpha-A at concentrations of 10^3 U/ml and higher.
  • While IFN alpha-C's effect on secondary growth was transient, IFN alpha-A demonstrated a persistent antiproliferative effect on self-renewal.

Conclusions:

  • Gene-cloned interferon subtypes possess significant in vitro antileukemic properties against acute myeloid leukemia.
  • Differential effects were observed among IFN subtypes regarding the suppression of primary myeloblast proliferation and the inhibition of cancer cell self-renewal.
  • These findings suggest potential for targeted interferon-based therapies in AML, with specific subtypes offering distinct advantages.